New Hope for Boys with Duchenne Muscular Dystrophy: FDA Grants Special Status to Experimental Drug Tegacorat
Grünenthal, a pharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has given two special designations to […]